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The increasing use of genetic information has emerged as an important concern 
worldwide as scientific and technological advances continue to advance at 
lightening speed and as governments struggle to develop appropriate policy 
frameworks.  While most countries clearly recognize that genetic information 
warrants some form of privacy protection, the underlying rationale for providing 
that protection and the approach which is ultimately adopted vary significantly 
across the board.  As a result, a medley of laws, policy statements and 
guidelines currently exist to protect genetic information, each with its inherent 
assumptions, concepts and terminology. 
 
This second edition of GenEdit will briefly examine the broad policy directions 
that have been taken at international, regional and national levels to protect 
genetic information, commenting on different approaches and some of the 
normative challenges associated with each. 
 
 
A. Use of Genetic Information in Health Care and Health Research  
 
For decades, health care providers have relied on genetic information obtained 
through family histories to prevent, monitor and assess the development of 
hereditary disorders. Through recent advances in genetic testing, clinicians can 
now combine familial history with the specific genetic makeup of individuals in 
order to better diagnose a patient’s existing disease or predict his/her risk of 
expressing a disease some time in the future.  In some cases, such information 
can provide patients with the opportunity for earlier and more effective treatment, 
better information on which to base their reproductive choices, or the necessary 
incentive to change lifestyle factors that may contribute to the risk of onset of 
disease. 
 
Understanding genetic information and its implications has also become a 
necessary and integral part of health research.  For example, there are many 
important research studies that aim to:   
 
 understand how genes account for different reactions to certain drugs; 
 establish common genetic variation within a particular group or different 
groups through population health studies; 
 find the genetic bases of diseases and develop new therapies; 
 understand the interactions of genes with other genes or with external 
factors (e.g. environmental, socio-economic factors, etc); and 
 evaluate the effectiveness of genetic testing in the delivery and 
organization of health services. 
 
B.  Regulatory Challenges 
 
Regulating the collection and use of genetic information poses significant 
challenges for legislators and policy-makers.  An international review of various 
policy instruments reveals that some jurisdictions have chosen to adopt special 
regimes tailored specifically to genetic information. Others have expressly 
expanded and adapted existing protections to cover this area.  Others still have 
yet to determine the most appropriate policy direction.  Several reasons may 
account for this difference in approaches.  
 
i. Nature of Genetic Information  
 
The first reason may be inherent to the nature of the information itself.  There is 
something about genetic information and the human tissue that contains that 
information which seems, instinctively at least, to have special status worthy of 
distinct legal treatment and protection.  Some of the arguments supporting the 
view that genetic information ought to be treated exceptionally are as follows:  
 
•   For some, genetic information is the most sensitive form of personal 
information that essentially defines individuals qua individuals. Through 
this lens, genetic information is regarded as having special status because 
it goes to the very core of our uniqueness as a human being and is the 
most intimate type of information about ourselves.   
 
•   While genetic information is specific to the traits of each individual, it is 
also revealing of common characteristics held by other family members.   
Hence, they too have a real interest in how genetic information about them 
is collected, used and disclosed. This challenges our traditional 
understanding of consent based on the principle of individual autonomy, 
since others who may also be affected by the individual’s choice now 
factors significantly into the equation. 
 
•   Extending the latter point even further, genetic information may be 
revealing of common traits held by broader communities, groups and 
populations.  The potential for discrimination and stigmatization of 
individuals, by sheer virtue of their association with a defined community, 
group or population that has a higher incidence of some genetic trait, 
whether or not the individuals themselves carry or express the gene, may 
negatively impact peoples’ access to certain services, as well as their 
opportunity to participate in and contribute meaningfully to society.    
 
•  Another feature of genetic information is the fact that, in some cases, it 
may indicate an existing trait that actually manifests itself in the individual, 
while in other cases, it indicates only a probability that the individual may 
one day manifest that trait later in life.  Some late onset conditions can be 
predicted with high certainty based on the presence of a single gene, 
while others depend on a host of other factors, including other genes, 
environmental influences, lifestyle choices, and socio-economic factors.  
Genetic test results are not always reliable, and even if they were, they do 
not lend themselves to easy interpretation.  Hence, there is a danger that 
ill-informed decisions may be made about the fate of individuals, families 
and larger communities, impacting on their rights and interests, based 
solely on their genes which may, or may never, express themselves as a 
disorder.  
 
•   Finally, there are sometimes arguments made about the special status 
of genetic information that are related, not to the nature of genetic 
information per se, but rather, to the human tissue as a record of that 
information.  Human tissue, or any human bodily substance - be it a skin 
or bone sample, a strand of hair, a drop of blood, or even nail clippings - 
contains a rather complete picture of who we are.  Everything from one’s 
gender, eye and hair colour, to one’s predisposition towards certain 
behaviour or risk of developing certain diseases can be contained in a tiny 
biological specimen that can remain intact for years, decades and 
arguably centuries.   
 
 
While many of these claims may be at the root of “genetic exceptionalism”, 
arguments to the contrary have demonstrated persuasively that genetic 
information is in fact not exceptional at all.  Genetic information raises, perhaps 
more acutely, many of the same issues raised by other types of personal 
information.   We agree with this view for several reasons. 
 
Sensitivity of personal information is a relative concept.  For some, the fact that 
they carry an obscure gene that has no significant meaning to the average 
layperson, may not be nearly as sensitive to them as is information about their 
financial situation or personal lifestyle.  In some circumstances, the fact that one 
family member suffers from an infectious disease or undertakes certain risky 
behaviour is information that can have profound impact on other family members, 
particularly dependents living in the same household.  Moreover, there are 
unfortunately many examples of discrimination against individuals based merely 
on their association with communities or groups that have shown higher 
incidence of disease as a result of certain risk factors – be they genetic or non-
genetic.  There are other types of information, quite apart from genetic 
information, that can be just as predictive of future health outcomes, such as, 
infectious diseases in their early asymptomatic stages, addition to alcohol or 
drugs, high levels of cholesterol or propensity towards risk.  Finally, the advent of 
modern information technology has made it increasingly possible to electronically 
process and link all types of personal information originating from multiple 
different sources, including genetic information derived from human tissue, thus 
creating an even more complete record of who we are. 
 
For these and other reasons, it is argued that there should not be a distinct legal 
regime to regulate the use of genetic data separately.  Rather, existing 
frameworks governing other types of personal information should be re-examined 
to address, in a more coherent fashion, the complex issues raised by genetics, 
but which are not specific to genetics.     
 
The difference in these views, that is, whether genetic information should be 
regulated distinctly or not, helps explain, in large measure, the difficult challenges 
faced by policy-makers in this area and the stark difference in directions they 
have taken to date. 
 
 ii. Proper Locus for Regulation 
 
Another challenge raised by genetic information is the difficulty to identify the 
proper locus for regulation.  Are there certain immutable principles we can agree 
to uphold at the international level and certain limits beyond which we all agree 
as a global society not to go?  To what extent should the choice of legal norms 
be deferred to the national, or even local level, in accordance with local value 
systems and socio-cultural differences?    
 
Moreover, what is it about genetic information that we wish to govern?  Is it the 
need to regulate the collection, use and disclosure of genetic information? or the 
need to prohibit criminal abuses of genetic information? or the need to protect the 
fundamental human right to equality notwithstanding that genetic information?   
Are we most concerned about the public or the private sector?  Does it, or should 
it, make a difference?  Is it the use of genetic information in the context of health 
and health research, or is it its potential access and use by employers, insurers 
and law enforcers that requires closest scrutiny and regulation?  Add to the mix 
federal-provincial division of legislative powers in a country like Canada, and 
other federal states, where each of these aspects and sectors of activity comes 
under different jurisdictions, and it is no wonder that policy-makers find this area 
challenging to regulate.  
 
In the absence of statutory norms, some countries have resorted to self-
regulation by professional corporations, governmental agencies and/or non-
governmental organizations.   Ethics guidelines or codes of conduct developed 
by such entities have the distinct advantage of being more flexible and closely 
connected to practical reality.  These ethics norms also promote moral 
introspection and inculcate a sense of moral responsibility among users of 
genetic information, in a way which laws pronounced from “on high” may not.  
This being said, however, ethics norms also raise questions about legitimacy and 
compliance.  By virtue of what legal authority or mandate can these entities 
determine what is or is not “ethical” and effectively regulate the use of genetic 
information in the absence of law?  In order to gain legitimacy under common 
law, ethics guidelines and codes of conduct have yet to demonstrate over time 
and usage that they indeed represent the standard of care that courts should 
expect of users of genetic information.  Unfortunately, there is often no 
systematic evaluation of how well ethics guidelines or codes of conduct fare in 
practice, nor any substantial evidence of the extent to which they are adopted 
and implemented.  Moreover, in cases of non-compliance, wrongdoers may not 
be as effectively sanctioned as they might otherwise be if these ethical norms 
had the force of law behind them.   
 
iii. Other Challenges 
 
Yet another challenge facing policy-makers is the rapid changing nature of 
genetic and information technologies.  How can policy be designed to effectively 
regulate the known, yet be sufficiently adaptable to capture the unknown?   
Advances in our understanding of the human genome and development of the 
necessary technologies to support further enquiry into the study of genomics 
were never even dreamed of a few years ago. Likewise, what will be possible 
tomorrow likely bears no resemblance to what we can anticipate today.   Adding 
to this is the continually expanding use of information technology and the Internet 
which makes it easier for many different custodians to access, store, link and 
analyze large amounts of genetic information with other personal information 
about individuals over time.  All of this activity contributes significantly to the 
complexity of the rules needed to govern it.    
 
Last, but not least, a major challenge facing policy-makers in the area of genetic 
information is the “yuk” factor.  Genetics is the “stuff” of science fiction.  For the 
average layperson, it engenders fears – fears that have been graphically 
depicted by Hollywood films and effectively amplified by newsy media headlines.  
These fears, whether or not they are justified or supported by broader public 
opinion, have tended to skew the policy debate.  In some jurisdictions, these 
fears have been used to mount effective pressure on politicians to do 
“something”, but with no clear indication of what that “something” ought to be.    
As a result, policy-makers face the challenge of sorting through the rhetoric in 
order to disentangle the real “mischief” that legislation ought to address. 
 
 
C. Different Normative Approaches 
 
In light of all these challenges and confounding factors, it is not surprising to find 
that many of the countries whose laws we reviewed have adopted different 
approaches for protecting genetic information.  Although the majority of 
jurisdictions recognize that genetic information needs to be protected, they have 
gone about ensuring that protection in a variety of ways.  We can distinguish four 
general approaches.  
 
  i. The Personal Information Approach Table I
The personal information approach encompasses genetic information within the 
broader definition of personal data (e.g. New Zealand) or nominative data (e.g. 
France).   The reference to genetic information is either made expressly or 
impliedly.  Jurisdictions may have specifically opted for this approach because 
they consider that the general regime they have in place, as is, provides 
sufficient protection to genetic information along with all other types of personal 
information.  Alternatively, some jurisdictions may not yet have made a 
determination either way about how they intend to protect genetic information 
and resort to their general privacy regime in the meantime to provide some 
protection.   Yet other jurisdictions (e.g. Canada) that include genetic information 
in their broad definition of personal information and subject it to the same rules, 
nonetheless build in a general provision calling for greater stringency in the 
application of those rules commensurate with the level of sensitivity of the data 
(leaving open to interpretation what is considered sensitive data depending on 
the type of information and the specific circumstances).   
 
The personal information approach has the advantage of setting out a 
comprehensive, coherent and principled regime for privacy protection that 
focuses on those socially acceptable purposes for which personal information 
may be collected, used and disclosed, how that ought to be done, and under 
what conditions.  It does not detract from that principled analysis by delineating 
different types or classes of personal information.  Although the personal 
information approach may well provide adequate protection for genetic 
information, it centers primarily on a consent model grounded in the principle of 
individual autonomy and hence, does not take into consideration important 
familial and communal interests in that information.    
 
  ii. The Sensitive Information Approach Table II 
The sensitive information approach expressly deems certain types of information 
to be sensitive based on the source of the information and the degree of intimacy 
related to it.  Designated categories of sensitive data include data relating to 
health, ethnic origin, political, religious and philosophical beliefs, criminal records, 
and sexual orientation (e.g. European Parliament, France (bill), Iceland).   
Typically, the sensitive information approach reverses the default position that 
exists under the general personal information approach.   That is, rather than 
allowing the processing of data subject to certain conditions, the sensitive data 
approach prohibits the processing for sensitive data unless it is required by law, it 
is for public health purposes, or if explicit consent is obtained.   
 
While the sensitive information approach affords a higher level of protection to 
certain categories of personal information than does the general personal 
information approach, it is not altogether that clear when and if genetic data falls 
within a specified class of sensitive data.  Moreover, even if genetic information 
were deemed sensitive, either expressly or impliedly via the inclusion of health 
data, the sensitive information approach still does not take into account the 
familial or communal dimension of genetic data.    
 
  iii. The Health (or Medical) Information Approach Table III 
 
The health (or medical information) approach provides a distinct normative 
regime for individually identifiable health or medical information (e.g. Australia, 
the U.S., some Canadian provinces (Alberta, Saskatchewan and Manitoba), 
World Medical Association and Council of Europe).  For the most part, genetic 
information is covered either expressly or impliedly by the definitions of health or 
medical information.  This approach often takes into consideration the interests 
and needs of family members who are involved in making decisions respecting 
the health of their loved ones. It also provides more detailed guidance on the 
conditions under which health or medical information may be used for care, 
education or research purposes - sometimes articulating special concern for the 
broader impact of research results on communities or groups.   
 
While the health or medical information approach affords a good level of 
protection to the information covered, it is limited in its scope of application. Often 
this model will only cover information kept by specific entities (i.e. medical 
facilities, government funded entities, public institutions, health data custodians 
or trustees, etc). Once the information flows outside the walls of the covered 
entities, the protective rules cease to apply.   Moreover, this model does not offer 
the advantage of overall coherence that the general personal information 
approach does.  Because this model sets out a distinct set of rules and separate 
oversight mechanisms, a genetic research project that aims to study the 
influence and interaction of multiple health determinants (as discussed above), 
can be subject to conflicting rules and different oversight bodies.  These 
differences from one regime to another add further to the already-existing 
jurisdictional differences that challenge national and international research. 
 
  iv. The Genetic Information Approach Table IV 
 
Finally, some jurisdictions favour the genetic information approach.  This 
approach creates a unique corpus of rules specific to genetic information (e.g. 
UNESCO, United Nations (draft), Israel). The genetic information approach has 
the obvious advantages of providing additional and more tailored protections 
specific to this type of information, while also addressing some of the familial and 
communal interests in that information.     
 
However, by its very nature, this approach is limited. Indeed, by attempting to 
address the ethical, social and legal issues raised by genetic information only, it 
necessarily ignores equally important issues raised by other types of personal 
information.  By affording special status to genetic information, this approach is 
then forced to define what constitutes genetic information and to distinguish it 
from other types of data, namely general personal information and health 
information. This leads to unnecessary confusion and creates potential sources 
of controversy, if not additional stigmatization of persons with genetic conditions.   
Finally, the same difficulties facing health researchers looking to study the 
influence and interaction of several health determinants are further compounded 
by this piecemeal approach that, once again, focuses on the type of information, 
rather than those socially acceptable purposes for which personal information 
may be collected, used and disclosed, how that ought to be done and under what 
conditions. 
 
 
D. Resolving the challenges 
 
While each approach has its benefits and disadvantages, it is ultimately the 
comprehensive, coherent and principled approach of the broader regimes 
covering personal information generally that we favour the most.  In our view, this 
approach appropriately organizes its rules according to purpose, rather than the 
type of information.  Even though the rules for collection, use and disclosure of 
personal information may be the same for a given purpose regardless of the type 
of personal information, this approach does not preclude a more stringent 
application of those same rules when sensitive data is involved, such as genetic 
information for instance.  We say “such as” because even if information is legally 
deemed to be sensitive under sensitive information approach, there may always 
be other types of information not formally recognized as such, but that are 
nonetheless sensitive in a given set of circumstances.  And it is precisely in those 
circumstances that the application of the required standards, as on a sliding 
scale, should be more exacting. 
 
Moreover, the personal information approach in no way forecloses the 
recognition of familial/community needs and interests in personal information.   
While some countries may be far away from formally entrenching these needs 
and interests into legal rights, they could nonetheless adapt their legal analysis 
that remains centred on individual autonomy, in a way that tempers that 
autonomy in view of the needs and interests of others. 
 
In conclusion, we encourage jurisdictions to consider expanding the personal 
information approach to 1) build in a requirement calling for stricter application of 
the same rules when sensitive information, such as genetic information is 
involved, and 2) expressly take into account family/community interests in 
personal information that up to now is understood as being only about an 
identifiable individual.  With the addition of these new concepts, jurisdictions may 
find that the benefits of a comprehensive, coherent and principled regime will 
displace the perceived need (as well as the political pressure) to treat genetic 
information distinctly from other types of data. 
 
I. PERSONAL INFORMATION APPROACH 
 
COUNTRY/ORGANIZATION SOURCE 
Canada 
Canadian Government, Personal Information Protection and Electronic 
Documents Act, S.C. 2000, c.5, http://laws.justice.gc.ca/en/P-
8.6/index.html (date accessed: September 10, 2003) 
France 
French Government, Loi no 78-17 du 6 janvier 1978, Loi relative à 
l’informatique, aux fichiers et aux libertés, 
http://www.cnil.fr/textes/text02.htm (date accessed: September 10, 
2003). It is important to note that this act provides specific guidance for 
the use of nominative data in healthcare and health research. 
New Zealand 
New Zealand Government, Privacy Act 1993, Auckland, 1993 No 28, 
http://www.legislation.govt.nz (date accessed: September 10, 2003). 
 
New Zealand Privacy Commissioner, Health Information Privacy Code, 
Auckland, June 28, 1994, 
http://www.privacy.org.nz/comply/HIPCWWW.pdf (date accessed: 
September 10, 2003). 
II. SENSITIVE INFORMATION APPROACH 
 
COUNTRY/ORGANIZATION SOURCE 
European Parliament 
Directive 95/46/EC of the European Parliament and of the Council of 24 
October 1995 on the protection of individuals with regard to the 
processing of personal data and on the free movement of such data, 
1995, 
http://europa.eu.int/smartapi/cgi/sga_doc?smartapi!celexapi!prod!CELE
Xnumdoc&lg=FR&numdoc=31995L0046&model=guichett (date 
accessed: September 10, 2003) 
Austria 
Austria Government, Federal Act concerning the Protection of Personal 
Data, Austria, August 17, 1999, 
http://www.bka.gv.at/datenschutz/dsg2000e.pdf (date accessed: 
September 10, 2003) 
Denmark 
Danish Parliament, Act on Processing of Personal Data, Denmark, June 
2, 2000, 
http://www.datatilsynet.dk/attachments/20001061548/ENGELSK%20LO
V.doc, (date accessed: September 10, 2003). 
Estonia 
Estonia Government, Personal Data Protection Act, Tallinn, 1996, 
http://www.esis.ee/legislation/protection.pdf (date accessed: September 
10, 2003) 
Finland 
Parliament of Finland, Personal Data Act, Finland, June 1, 1999, 
http://www.tietosuoja.fi/uploads/hopxtvf.HTM (date accessed: 
September 10, 2003) 
France 
(bill) 
French Government, Projet de loi, modifié par le sénat, relatif à la 
protection des personnes physiques à l’égard des traitements 
de données à caractère personnel et modifiant la loi n° 78-17 du 
6 janvier 1978 relative à l’informatique, aux fichiers et aux 
libertés, April 1 2003, http://www.cnil.fr/textes/docs/CNIL-Loi78-
17_modSenat1-VI.pdf (date accessed: September 10, 2003). 
Germany 
German Government, Federal Data Protection Act, Germany, May 23, 
2001, http://www.bfd.bund.de/information/bdsg_eng.pdf (date accessed: 
September 10, 2003) 
Greece 
Greek Government, Law 2472/1997 on the Protection of Individuals with 
regard to the Processing of Personal Data, Athens, April 9, 1997, 
http://www.dpa.gr/Documents/Eng/2472engl_all.doc (date accessed: 
September 10, 2003) 
Iceland 
Parliament of Iceland, Act on Protection of Individuals with regard to the 
Processing of Personal Data No. 77/2000, Iceland, January 1, 2000, 
http://www.mannvernd.is/english/laws/Act.DataProtection.html (date 
accessed: September 10, 2003). It is interesting to note that in Iceland 
the definition of sensitive data directly refers to genetic information. 
Italy 
Italian Data Protection Commission, Protection of Individuals and Other 
Subjects With Regard to the Processing of Personal Data, ACT no. 675, 
December 31, 1996, http://www.privacy.it/legge675encoord.html (date 
accessed: September 10, 2003). 
Netherlands 
   Dutch Government, Personal Data Protection Act, 25 892, 
Netherlands, November 23, 1999, 
http://www.cbpweb.nl/en/documenten/en_pdpa.htm (date accessed: 
September, 2003) 
Norway 
Norway Government, Act of 14. April 2000 No. 31 relating to the 
Processing of Personal Data (Personal Data Act), Oslo, April 14, 2000, 
http://www.datatilsynet.no/lov/loven/poleng.html (date accessed: 
September 10, 2003). 
Portugal 
Portugal Government, Act no 67/98 of 26 October - Act on the 
Protection of Personal Data, Portugal, October 26, 1998, 
http://www.cnpd.pt/Leis/lei_6798en.htm (date accessed: September 10, 
2003) 
Spain 
Spain Government, Organic Law 15/1999 of 13 December on the 
Protection of Personal Data, Spain, December 13, 1999, 
https://www.agenciaprotecciondatos.org/ley_15_ingles_v2_pdf.pdf (date 
accessed: September 10, 2003). 
Sweden 
Sweden Government, Personal Data Act (1998:204), Sweden, April 29, 
1998, http://www.datainspektionen.se/PDF-filer/ovrigt/pul-eng.pdf (date 
accessed: September 10, 2003) 
Switzerland 
Swiss Government, Federal Law on Data Protection, Switzerland, July 
1, 1993, http://www.edsb.ch/e/gesetz/schweiz/dsge.pdf (date accessed: 
September 10, 2003) 
United Kingdom 
Parliament United Kingdom, Data Protection Act 1998, United Kingdom, 
July 16, 1998, 
http://www.legislation.hmso.gov.uk/acts/acts1998/19980029.htm (date 
accessed: September 10, 2003) 
 
 
 
III. MEDICAL INFORMATION APPROACH 
 
COUNTRY/ORGANIZATION SOURCE 
World Medical Association 
World Medical Association (WMA), Declaration on Ethical 
Considerations regarding Health Databases, Washington, October 6, 
2002, http://www.wma.net/e/policy/d1.htm (date accessed : 
September 10, 2003) 
Australia 
Australian Government, Privacy Act 1988 (Act No. 119 of 1988 as 
amended), Australia, 
1988, http://austlii.edu.au/privacy/Privacy_Act_1988/index-
Privacy.html (date accessed: September 10, 2003). 
 
National Health and Medical Research Council, Guidelines Under 
Section 95 of the Privacy Act 1988, 2000, 
http://www.nhmrc.gov.au/publications/pdf/e26.pdf   (date accessed: 
September 10, 2003). 
 
National Health and Medical Research Council, Guidelines Under 
Section 95A of the Privacy Act 1988, 2001, 
http://www.nhmrc.health.gov.au/publications/pdf/e43.pdf (date 
accessed: September 10, 2003). 
Council of Europe 
Council of Europe (CE), Recommendation No. R (97)5 of the 
Committee of Ministers to Member States on the Protection of 
Medical Data, 1997, http://www.coe.fr/cm/ta/rec/1997/97r5.html (date 
accessed: September 10, 2003). 
The United States 
Department of Health and Human Services, Standards for Privacy of 
Individually Identifiable Health Information, 45 C.F.R. §§ 160 & 164 
(2002) http://www.hhs.gov/ocr/hipaa/finalreg.html (date accessed: 
September 10, 2003). 
 
IV. GENETIC INFORMATION APPROACH 
 
COUNTRY/ORGANIZATION SOURCE 
UNESCO 
International Bioethics Committee, International Declaration on 
Human Genetic Data, Paris, October 16, 2003, 
http://unesdoc.unesco.org/images/0013/001312/131204e.pdf#page=
27 (date accessed : October 29, 2003) 
United Nations 
(Draft) 
Economic and Social Council, Argentina: Draft Resolution - Genetic 
Privacy and Non-Discrimination, Geneva, July 27, 2001, 
http://www.un.org/documents/ecosoc/docs/2001/e2001-l24rev1.pdf 
(date accessed: September 10, 2003) 
Israel 
Genetic Information Law, 5761-2000", (2000), December 13, 
2000, http://www.auco.justice.gov.il/MOJHeb/resources/genetic+infor
mation+law-edited_050901.doc (date accessed : September 10, 
2003) 
 
